Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership
Cancer Res
.
2012 Mar 1;72(5):1055-8.
doi: 10.1158/0008-5472.CAN-11-3439.
Epub 2012 Jan 13.
Authors
Scott J Weir
1
,
Louis J DeGennaro
,
Christopher P Austin
Affiliation
1
Institute for Advancing Medical Innovation, University of Kansas Cancer Center, Kansas City, Kansas, USA. sweir@kumc.edu
PMID:
22246671
PMCID:
PMC3341848
DOI:
10.1158/0008-5472.CAN-11-3439
No abstract available
MeSH terms
Auranofin / therapeutic use
Drug Discovery
Drug Repositioning*
Humans
Neoplasms / drug therapy*
Neoplasms / prevention & control
Patents as Topic
Public Policy
Public-Private Sector Partnerships*
Substances
Auranofin
Grants and funding
ZIB HG200319-08/ImNIH/Intramural NIH HHS/United States